We argue against selling Geron at current prices, citing strong market potential of imetelstat and Royalty Pharma deal ...

Researchers studying gene expression have access to vast amounts of data from cells or tissues. This is thanks to advances in ...

Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines.

We feel sorry because we cry,' wrote philosopher and psychologist William James, 'angry because we strike, afraid because we tremble,' suggesting that emotional bodily responses like crying cause ...

Learn more about whether Protagonist Therapeutics, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

This study presents solid evidence for distinct neurotransmitter release modalities between two subclasses of dopaminergic neurons in the olfactory bulb, highlighting an important finding that ...

Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2025. At this time, all participants have been placed in a listen-only mode and the call will ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Wednesday, February 05, 2025. Let’s ...

Presentation Unidentified Speaker Thank you. Thank you, Julianne. Good afternoon, everyone, and welcome to our 4th-quarter ...

Bio-Techne Corp (NASDAQ:TECH) reported stronger-than-expected earnings for the second quarter of fiscal year 2024, with adjusted earnings per share (EPS) of $0.42, surpassing the forecasted $0.39.

micro RNAs (miRNAs) are a type of non-coding RNA (ncRNA), ~21 24 nucleotides in length, that function in the post-transcriptional regulation of gene expression. Typically miRNAs interact with ...

Every decision made, from what movie to watch to what career to pursue, results in both positive and negative aspects. We all make these decisions every day. We decide for ourselves. We decide for ...